SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-066002
Filing Date
2018-11-05
Accepted
2018-11-05 16:49:05
Documents
8
Effectiveness Date
2018-11-05

Document Format Files

Seq Description Document Type Size
1 DFAN14A a18-39578_1dfan14a.htm DFAN14A 44595
2 GRAPHIC g395781bgi001.gif GRAPHIC 320231
3 GRAPHIC g395781bgi002.gif GRAPHIC 188406
4 GRAPHIC g395781bgi003.gif GRAPHIC 55675
5 GRAPHIC g395781bgi004.gif GRAPHIC 106589
6 GRAPHIC g395781bgi005.gif GRAPHIC 89038
7 GRAPHIC g395781bgi006.gif GRAPHIC 95250
8 GRAPHIC g395781bgi007.gif GRAPHIC 55810
  Complete submission text file 0001104659-18-066002.txt   1300898
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Subject) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-35050 | Film No.: 181160479
SIC: 2834 Pharmaceutical Preparations